ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safety. Matulonis UA, Herrstedt J, Oza A, Mahner S, et al. Gynecol Oncol 2025;195:192-199.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Matulonis UA, Herrstedt J, Oza A, Mahner S, et al. ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safety. Gynecol Oncol 2025;195:192-199.
PMID: 40139026